| Breast cancer risk genes—association analysis in more than 113,000 women Breast Cancer Association Consortium New England Journal of Medicine 384 (5), 428-439, 2021 | 619 | 2021 |
| An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity O Kopper, CJ De Witte, K Lõhmussaar, JE Valle-Inclan, N Hami, L Kester, ... Nature medicine 25 (5), 838-849, 2019 | 593 | 2019 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| RAD51 135G→ C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies AC Antoniou, OM Sinilnikova, J Simard, M Léoné, M Dumont, ... The American Journal of Human Genetics 81 (6), 1186-1200, 2007 | 306 | 2007 |
| The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study S de Groot, MPG Vreeswijk, MJP Welters, G Gravesteijn, JJWA Boei, ... BMC cancer 15, 1-9, 2015 | 252 | 2015 |
| Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial … NV Morgan, MR Morris, H Cangul, D Gleeson, A Straatman-Iwanowska, ... PLoS genetics 6 (2), e1000833, 2010 | 207 | 2010 |
| Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial S de Groot, RT Lugtenberg, D Cohen, MJP Welters, I Ehsan, ... Nature communications 11 (1), 3083, 2020 | 199 | 2020 |
| Functional Ex Vivo Assay to Select Homologous Recombination–Deficient Breast Tumors for PARP Inhibitor Treatment KAT Naipal, NS Verkaik, N Ameziane, CHM van Deurzen, P Ter Brugge, ... Clinical Cancer Research 20 (18), 4816-4826, 2014 | 186 | 2014 |
| A guide for functional analysis of BRCA1 variants of uncertain significance GA Millot, MA Carvalho, SM Caputo, MPG Vreeswijk, MA Brown, M Webb, ... Human mutation 33 (11), 1526-1537, 2012 | 165 | 2012 |
| Tumor slice culture system to assess drug response of primary breast cancer KAT Naipal, NS Verkaik, H Sánchez, CHM van Deurzen, MA den Bakker, ... BMC cancer 16, 1-13, 2016 | 158 | 2016 |
| Frequent homologous recombination deficiency in high-grade endometrial carcinomas MM de Jonge, A Auguste, LM van Wijk, PC Schouten, M Meijers, ... Clinical Cancer Research 25 (3), 1087-1097, 2019 | 145 | 2019 |
| Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2 L Guidugli, A Carreira, SM Caputo, A Ehlen, A Galli, ANA Monteiro, ... Human mutation 35 (2), 151-164, 2014 | 133 | 2014 |
| Association of ESR1 gene tagging SNPs with breast cancer risk AM Dunning, CS Healey, C Baynes, AT Maia, S Scollen, A Vega, ... Human molecular genetics 18 (6), 1131-1139, 2009 | 129 | 2009 |
| BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk AB Spurdle, PJ Whiley, B Thompson, B Feng, S Healey, MA Brown, ... Journal of medical genetics 49 (8), 525-532, 2012 | 128 | 2012 |
| The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians S Knappskog, M Bjørnslett, LM Myklebust, PEA Huijts, MP Vreeswijk, ... Cancer cell 19 (2), 273-282, 2011 | 128 | 2011 |
| Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice‐site prediction programs MPG Vreeswijk, JN Kraan, HM van der Klift, GR Vink, CJ Cornelisse, ... Human mutation 30 (1), 107-114, 2009 | 125 | 2009 |
| Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification MT Parsons, E Tudini, H Li, E Hahnen, B Wappenschmidt, L Feliubadaló, ... Human mutation 40 (9), 1557-1578, 2019 | 121 | 2019 |
| UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice GTJ Van Der Horst, L Meira, TGMF Gorgels, J De Wit, S Velasco-Miguel, ... DNA repair 1 (2), 143-157, 2002 | 117 | 2002 |
| Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases PEA Huijts, MPG Vreeswijk, KHG Kroeze-Jansema, CE Jacobi, ... Breast Cancer Research 9, 1-9, 2007 | 116 | 2007 |
| Analysis of repair of cyclobutane pyrimidine dimers and pyrimidine 6-4 pyrimidone photoproducts in transcriptionally active and inactive genes in Chinese hamster cells. MP Vreeswijk, A Van Hoffen, BE Westland, H Vrieling, AA Van Zeeland, ... Journal of Biological Chemistry 269 (50), 31858-31863, 1994 | 101 | 1994 |
